Q1 2024 13F Holders as of 31 Mar 2024
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
14,125,652
-
Share change
-
+1,684,550
-
Total reported value
-
$61,021,335
-
Put/Call ratio
-
158%
-
Price per share
-
$4.32
-
Number of holders
-
82
-
Value change
-
+$8,686,692
-
Number of buys
-
48
-
Number of sells
-
34
Institutional Holders of G1 THERAPEUTICS INC - COM (GTHX) as of Q1 2024
As of 31 Mar 2024,
G1 THERAPEUTICS INC - COM (GTHX) was held by
82 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
14,125,652 shares.
The largest 10 holders included
VANGUARD GROUP INC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, RENAISSANCE TECHNOLOGIES LLC, RAYMOND JAMES & ASSOCIATES, D. E. Shaw & Co., Inc., BlackRock Inc., GEODE CAPITAL MANAGEMENT, LLC, GOLDMAN SACHS GROUP INC, MILLENNIUM MANAGEMENT LLC, and ACADIAN ASSET MANAGEMENT LLC.
This page lists
82
institutional shareholders reporting positions in this security
for the Q1 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.